Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
92.53
+0.84 (0.91%)
Nov 5, 2025, 12:51 PM EST - Market open
Revvity Employees
Revvity had 11,000 employees as of December 29, 2024. The number of employees decreased by 500 or -4.35% compared to the previous year.
Employees
11,000
Change (1Y)
-500
Growth (1Y)
-4.35%
Revenue / Employee
$255,761
Profits / Employee
$21,589
Market Cap
10.74B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 29, 2024 | 11,000 | -500 | -4.35% |
| Dec 31, 2023 | 11,500 | -5,200 | -31.14% |
| Dec 31, 2022 | 16,700 | 0 | - |
| Dec 31, 2021 | 16,700 | 2,700 | 19.29% |
| Dec 31, 2020 | 14,000 | 1,000 | 7.69% |
| Dec 31, 2019 | 13,000 | 500 | 4.00% |
| Dec 31, 2018 | 12,500 | 1,500 | 13.64% |
| Dec 31, 2017 | 11,000 | 3,000 | 37.50% |
| Dec 31, 2016 | 8,000 | 0 | - |
| Dec 31, 2015 | 8,000 | 300 | 3.90% |
| Dec 31, 2014 | 7,700 | 100 | 1.32% |
| Dec 31, 2013 | 7,600 | 100 | 1.33% |
| Dec 31, 2012 | 7,500 | 300 | 4.17% |
| Dec 31, 2011 | 7,200 | 1,000 | 16.13% |
| Dec 31, 2010 | 6,200 | -2,000 | -24.39% |
| Dec 31, 2009 | 8,200 | 300 | 3.80% |
| Dec 31, 2008 | 7,900 | -800 | -9.20% |
| Dec 31, 2007 | 8,700 | 200 | 2.35% |
| Dec 31, 2006 | 8,500 | 500 | 6.25% |
| Dec 31, 2005 | 8,000 | -2,000 | -20.00% |
| Dec 31, 2004 | 10,000 | 0 | - |
| Dec 31, 2003 | 10,000 | -700 | -6.54% |
| Dec 31, 2002 | 10,700 | -100 | -0.93% |
| Dec 31, 2001 | 10,800 | -1,700 | -13.60% |
| Dec 31, 2000 | 12,500 | 500 | 4.17% |
| Dec 31, 1999 | 12,000 | -1,000 | -7.69% |
| Dec 31, 1998 | 13,000 | -1,000 | -7.14% |
| Dec 31, 1997 | 14,000 | -1,000 | -6.67% |
| Dec 31, 1996 | 15,000 | 0 | - |
| Dec 31, 1995 | 15,000 | -10,000 | -40.00% |
| Dec 31, 1994 | 25,000 | -7,000 | -21.88% |
| Dec 31, 1993 | 32,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RVTY News
- 8 days ago - Revvity Analysts Increase Their Forecasts After Q3 Earnings - Benzinga
- 8 days ago - Revvity to Present at Upcoming Investor Conferences - Business Wire
- 9 days ago - Revvity: Software Momentum And Screening Offset China Weakness - Seeking Alpha
- 9 days ago - Revvity, Inc. (RVTY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Revvity lifts annual profit forecast on renewed demand in diagnostics unit - Reuters
- 9 days ago - Revvity Announces Financial Results for the Third Quarter of 2025 - Business Wire
- 12 days ago - Revvity Board Declares Quarterly Dividend - Business Wire
- 22 days ago - Revvity Showcases Progress with Purpose in 2025 Impact Report - Business Wire